Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis
Table 2
Baseline characteristics of the SCIT patients.
Variable
SCIT patients ()
Age: years
31.8 (10.8)
Sex: male/female
52/42
BMI, kg/m2
22.7 (1.4)
Disease duration, years
4.6 (2.6)
Smoking, yes/no
16/78
Alcohol consumption, yes/no
9/85
nNO, ppb
707.7 (287.1)
Serum NOS2(IU/ml)
6.6 (1.7)
Allergic comorbidities
AS
19
AC
75
Baseline VAS
6.2 (2.2)
Nasal congestion
2.0 (0.8)
Runny nose
2.1 (0.8)
Sneeze
2.2 (0.7)
Itchy nose
1.8 (0.8)
Baseline TNSS
6.3 (1.7)
BMI: body mass index; nNO: nasal nitric oxide; ppb: parts per billion; AS: allergic asthma; AC: allergic conjunctivitis; TNSS: total nasal symptom score; VAS: visual analogue scale.
